Macquarie Group LTD Ardelyx, Inc. Transaction History
Macquarie Group LTD
- $79.1 Billion
- Q2 2025
A detailed history of Macquarie Group LTD transactions in Ardelyx, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 11,457,557 shares of ARDX stock, worth $64.2 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
11,457,557
Previous 11,158,139
2.68%
Holding current value
$64.2 Million
Previous $54.8 Million
18.02%
% of portfolio
0.06%
Previous 0.07%
Shares
12 transactions
Others Institutions Holding ARDX
# of Institutions
222Shares Held
167MCall Options Held
517KPut Options Held
1.61M-
Black Rock Inc. New York, NY17.6MShares$98.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$89.8 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X015.1MShares$84.3 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny11.7MShares$65.3 Million0.02% of portfolio
-
Marshall Wace, LLP London, X011.3MShares$63 Million0.05% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $866M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...